OUR FOCUS - HELP & RESEARCH
Welcome to Keratoderma.org. We offer support, advice and information to keratoderma patients.
REGISTER WITH US
Do you or a family member have keratoderma? If so, then please register with keratoderma.org. We are building a worldwide database of patients to enable future trials of new medicines.
How can we help you? Information about various types of keratoderma can be found here, as well as details of how to obtain genetic testing for inherited forms of keratoderma.
Want to meet others with keratoderma, as well as expert doctors and scientists working on these conditions? Details of forthcoming patient support meetings can be found here.
Can you help us to help you? We are a not-for-profit patient support organisation. Our activities depend on funds raised by the public. Ways to donate can be found here.
Keratoderma.org is a patient advocacy organisation for patients with palmoplantar keratoderma
What is palmoplantar keratoderma?
‘Keratoderma’ is a term that means marked thickening of the skin.
‘Palmoplantar’ refers to the skin on the soles of the feet and palms of the hands; these are the areas keratoderma affects most often. The terms "keratoderma" and "palmoplantar keratoderma" are used interchangably. Palmoplantar keratoderma is also sometimes known as ‘keratosis palmaris et plantaris’.
Classification of keratodermas depends on whether or not it is inherited, and its clinical features.
• Diffuse keratodermas affect most of the palms and soles.
• Focal keratodermas mainly affect pressure areas.
• Punctate-type keratodermas result in tiny bumps on the palms and soles.
Most often the abnormal skin involves only the palms and soles (non-transgradient) but sometimes it extends on to the top of the hands and feet as well (transgradient).
In a few rare forms of keratoderma other organs in the body may be affected in addition to the skin and in these cases, the keratoderma can be a marker of this more general abnormality.
LATEST NEWS & EVENTS
For up to date information from Keratoderma.org
Other names sometimes used for EPPK: Vörner’s syndrome or PPK (Vörner type) Gene or genes involved: Keratin 9 (gene symbol KRT9; protein symbol K9) and Keratin 1 (gene symbol KRT1; protein symbol K1) Introduction Epidermolytic palmoplantar keratoderma or EPPK, is one of the more common forms of inherited keratoderma (palmoplantar keratoderma – PPK – thick[…]
Patients with a rare disease present unique challenges for primary care providers (PCPs). Obstacles to caring for these patients include diagnostic delays and a lack of information, expertise, and treatment options for many rare diseases. PCPs play a vital role in enhancing the quality of life for patients and families living with a rare disease[…]
The International Rare Diseases Research Consortium (IRDiRC) is proud to announce the new vision and goals for 2017-2027. IRDiRC, officially launched in 2011, was originally conceived with two main goals: to contribute to the development of 200 new therapies and the means to diagnose most rare diseases by the year 2020. The last six years[…]
1 March 20188:30 a.m.–4:00 p.m. ET NIH CampusMasur Auditorium, Building 10NIH Clinical CenterBethesda, Maryland Sponsored by NCATS and the NIH Clinical Center, Rare Disease Day at NIH will take place on March 1, 2018 in Masur Auditorium, Building 10 on the NIH main campus in Bethesda. NCATS Director Christopher P. Austin, M.D., will provide opening[…]
On 2 April 2018 we will be launching keratoderma.org. This is a website to help keratoderma patients and their families by setting up a patient support organisation. We aim to fill it with information about keratoderma, details of events and news as well as a register of patients to receive email updates on new therapies[…]